Please extend the analysis of cell cycle progression and apoptotic rates (ref #1 and #3) -> The referees all raise concerns about the strength and significance of the effects seen on the rate of histone modifications. It will therefore be central for you to strengthen this aspect of the manuscript further, preferentially via the inclusion of additional replicas as requested by ref #2 -> Please also include additional data on the interplay between different histone modifications at the TSS as well as the link between the transcriptional changes observed and the altered rate of ES cell proliferation (ref #1 and ref #3) Given the referees' overall positive recommendations, I would like to invite you to submit a revised version of the manuscript, addressing the comments of all three reviewers. I should add that it is
Thank you for submitting your manuscript for consideration by the EMBO Journal and my apologies for the slightly extend review period here. Your study has now been seen by three referees whose comments are shown below.
As you will see from the reports, all referees express interest in the findings reported in your manuscript, although they also raise a number of concerns that will have to be addressed before they can support publication in The EMBO Journal.
For a revised version of the manuscript I would particularly ask you to focus your efforts on the following points: -> Please extend the analysis of cell cycle progression and apoptotic rates (ref #1 and #3) -> The referees all raise concerns about the strength and significance of the effects seen on the rate of histone modifications. It will therefore be central for you to strengthen this aspect of the manuscript further, preferentially via the inclusion of additional replicas as requested by ref #2 -> Please also include additional data on the interplay between different histone modifications at the TSS as well as the link between the transcriptional changes observed and the altered rate of ES cell proliferation (ref #1 and ref #3) Given the referees' overall positive recommendations, I would like to invite you to submit a revised version of the manuscript, addressing the comments of all three reviewers. I should add that it is
3) The H3K9me3 ChIP-seq data need to be more carefully interpreted. Average TSS profiles ( Figure  5a ) may simply reflect changes in nucleosome density at transcriptional start sites. This needs to be controlled using Input and Histone H3 ChIP controls. The heatmap in Figure 5b actually shows that H3K9me3 is only enriched on a small subset of transcriptional start sites which is actually consistent with previous reports on this modification. Most TSS only show background levels. In order to understand how Jmjd2a/c affect transcriptional regulation, the authors should focus on genes on which substantial levels of H3K9me3 (either in control or mutant) can be detected. I would assume that the validation ChIP-qPCR analyses ( Figure 5c ) were performed on exactly such targets. In addition, the correlation between changes in H3K9me3 and changes in gene expression ( Figure 6 ) need to be clarified, again by focusing on the genes showing substantial enrichment of H3K9me3.
4) On genes showing substantial changes in H3K9me3 in Jmjd2a/c ko ES cells, is H3K4me3 altered?
5) The model in its current form is not very precise. It is clear that Jmjd2a/c prevent aberrant accumulation of H3K9me3 at least on a subset of target genes. This may directly impact on the transcriptional regulation (see point 3). If H3K36me3 is directly affected by Jmjd2a/c is currently unclear (discussion to Figure 6d ). Furthermore it is unclear how the transcriptional changes in Jmjd2a/c ko ES cells impact on ES cell proliferation and cell identity. If H3K9me3 coexists with H3K4me3 (or if H3K4me3 is altered in the ko cells) was not demonstrated.
6) The materials and methods section needs to be expanded to better explain statistical tests (especially in the context of NGS analyses) and to list all reagents (e.g. primers).
Referee #2:
This study explores the in vivo and cellular phenotypes of deleting histone demethylases in the mouse. These are highly relevant and necessary experiments to explore potential redundancies of these enzymes, which are important for our understanding of chromatin biology and which are furthermore currently pursued as drug targets.
The in vivo experiments appear to be done at high quality and they reveal that either deletion of Jmjd2a or Jmjd2c is lethal in vivo. Combined knockouts appear to be not viable given the failure to obtain born pups or even at DPC 6.5. To further explore cellular phenotypes the authors study ES cells. Their results suggest impaired self-renewal of either a/c DKO or a/b/c TKO and spontaneous differentiation into towards extraembryonic endoderm. The authors aim further to link the phenotype to differences in the histone modifications that are the putative substrates for these enzymes. This part of the work seems less convincing in the current version of the manuscript. The observed differences genome-wide ( Figure 5 ) seem subtle and in order to be sustainable it would need to be shown with more details and statistical tests that wildtype and mutant cells are similarly different between independent wildtype and mutant clones and replicates. This appears necessary since no two genome-wide experiments are so similar that no statistically significant difference could be obtained given the large numbers of measurement points. The question is thus if replicates of the same genotype are more similar than those with other genotype. In the current manuscript however I could not find information on potential numbers of replicates and/or the use of independent clones for the Chip-Seq studies. Since the authors provide data of two different mutant clones (a/c and a/b/c) they should be able to do a pairwise comparison between mutants in addition to providing a reproducibility measure. I am fully aware that these are expensive experiments but while repeats are required in any case this is even more needed in case of the observed subtle effects. Ideally genome-wide profiling should also include the add back catalytic active and catalytic dead Jmjd2c, which the authors already have generated and which do show reversal of the phenotype using western blot and signal at selected genes ( Figure 7 and S7). If these needed ChIP-Seq experiments confirm a reproducible effect that depends on the presence of a catalytic active enzyme this manuscript seems highly suitable for EMBO journal.
Referee #3:
Manuscript: Continual removal of H3K9 mehylation by jmjd2 demethylases is vital for ESC selfrenewal and early development.
Pedersen and colleagues present mouse knockout data for Jmjd2a and Jmjd2a that strongly support a redundant role within ESCs. Their evidence is based on phenotypic and genome-wide sequencing experiments. Overall, the data and manuscript are well developed. There are a few points that should be addressed before being published.
Concerns:
1-This manuscript builds the case they are redundant and bind the same positions. Do they bind at the same time? Chip-reChip would be required at the targets elucidated. Do these proteins interact in vivo (not with forced overexpression)? 2-Are the authors' sure that Jmjd2a enzyme activity are required. They show Jmjd2c but not Jmjd2a. In Drosophila, the activity was not required. 3-The heat maps are often hard to interpret because the experimental verssu controls are hard to separate. Examples in supplement and Figure 5b . The H3K36me3 data should be included in Figure  5 . 4- Figure 6d does not match the text description. It seems up-regulated and no change both have clear increase in K36me3. So how does transcription explain the observation? Also up-regualted in the not-bound show no change in K36me3. 5-The graph throughout need stats. For Figure 2i ,j, there needs to be expanded graph so can see if changes occur. 6-The manuscript starts with endoderm association and then does not relate the molecular results to this other than develop GO. This aspect needs better development. 7-The cell cycle analyses in Figure 2 show a modest affect. This should be stated and not underplayed. It could be more pronounced in vivo. Annexin or some other method should be used to evaluate the "apoptosis". 8-The data in Figure S5a needs quantification. The data does not suggest or prove the enzymes are responsible for demethylation to H3K9me1. This suggestion should be softened.
Minor comment:
The authors' should conform to the nomenclature for the lysine demethylases or mention the names so that readers can find this study. As suggested by the referee, we have altered the Figure 2E so that the proportion of dead cells (subG1, events with a <2N DNA content) is now clearly indicated. In order to provide a measure for apoptotic cell death, we performed Western blot analyses of cleaved Caspase 3, and the data are presented in Appendix Fig S2A. 
2) Global changes in histone modifications should be quantified (Figure S5a). Alternatively, the authors could simply tone down their statement about the extent of global changes.
We have quantified the western blots (now Fig EV2A) and these quantifications are presented in Fig  EV2B in the revised form of the manuscript. Each blot for histone methylation was re-probed with an antibody recognizing histone H4, and this was used for normalization.
Additionally, the text describing the data has been modified and now reads 'The Jmjd2 enzymes catalyse the demethylation of lysine 9 and lysine 36 on histone H3 and increased levels of H3K9me3 and H3K36me3 could be detected for both 2ac and 2abc KO ESCs by WB'.
3) The H3K9me3 ChIP-seq data need to be more carefully interpreted. Average TSS profiles ( Figure  5a ) may simply reflect changes in nucleosome density at transcriptional start sites. This needs to be controlled using Input and Histone H3 ChIP controls.
In order to control for changes in nucleosome density, we included histone H3 controls in all ChIP qPCR validations, and we furthermore normalized all ChIP qPCR signals to input. Additionally, we have now included results from H3 ChIP-seq experiments. As shown in Fig In the revised form of the manuscript, we furthermore identify the TSS regions with the greatest increase in H3K9me3 levels upon OHT treatment across ChIP-seq datasets for different 2ac and 2abc ESC lines (Fig EV4) . To examine if the downstream genes show impaired transcription, we've taken advantage of our microarray data, and as shown in Fig 6E we find that the majority of corresponding genes are indeed down-regulated in the OHT treated cells. Additionally, the profiles presented in Fig 6C and Fig EV5 demonstrate that Jmjd2a/c targets with impaired transcription in KO ESCs generally display increased H3K9me3 levels. Combined these data strongly support the conclusion that Jmjd2-mediated control of H3K9 methylation affects gene transcription.
4) On genes showing substantial changes in H3K9me3 in Jmjd2a/c ko ES cells, is H3K4me3 altered?
To address this question, we have performed ChIP-seq for H3K4me3 in 2ac and 2abc ESC lines and confirmed the results by independent ChIP-qPCR validations. As shown in the new Fig EV3A and EV4, we find that the overall H3K4me3 levels are largely unaltered in DKO/TKO ESCs, but observe a decrease in H3K4me3 levels over the TSS regions with the most substantial accumulation of H3K9me3. We discuss these findings in the manuscript.
5) The model in its current form is not very precise. It is clear that Jmjd2a/c prevent aberrant accumulation of H3K9me3 at least on a subset of target genes. This may directly impact on the transcriptional regulation (see point 3). If H3K36me3 is directly affected by Jmjd2a/c is currently unclear (discussion to Figure 6d). Furthermore it is unclear how the transcriptional changes in Jmjd2a/c ko ES cells impact on ES cell proliferation and cell identity. If H3K9me3 coexists with H3K4me3 (or if H3K4me3 is altered in the ko cells) was not demonstrated.
Our model is a working model, and it is not clear whether histone marks coexist on the same nucleosome tail as schematized in the model. However, in response to all reviewer comments, we have considerably expanded the data regarding the role of Jmjd2a/c in regulating the chromatin landscape surrounding H3K4me3 positive TSSs and how loss of that regulation impacts transcription. We show that lack of Jmjd2a/c (on average) results in spreading of H3K9me3 over the TSSs, as well as a shift of H3K36me3 towards the TSS. Furthermore, we demonstrate a clear link between the accumulation of H3K9me3 and loss of transcriptional competence. Also, we identify several Jmjd2a/c target genes with roles in ESC self-renewal, embryogenesis and cell cycle regulation that could contribute to the observed phenotypes (page 15). Taken these data into consideration, we believe that Figure 8 constitutes a good working model.
6) The materials and methods section needs to be expanded to better explain statistical tests (especially in the context of NGS analyses) and to list all reagents (e.g. primers).
We have expanded the materials and methods section, and it now contains more information on statistical testing, as well as all reagents. All primers are now listed in Table EV3 . (Fig EV2C-D) . The new experiments thus confirm that the observed effects on H3K9me3 and H3K36me3 are highly reproducible.
Additionally, analyses of the new ChIP-seq datasets further substantiate the link between Jmjd2-dependent control of H3K9me3 levels and transcriptional regulation. In this way, all ChIP-seq datasets show increased levels of H3K9me3 at Jmjd2a/c targets with impaired transcription upon loss of Jmjd2a/c function (Fig EV5) . Reciprocally, we find that genes with a substantial increase in H3K9me3 levels after OHT treatment are transcribed at reduced levels ( Fig EV4A and Fig 6E) . These data -together with the rescue experiments presented in Fig 7 - further support the conclusion that Jmjd2a/c dependent regulation of histone methylation is essential for ESC transcriptional competence and self-renewal.
Manuscript: Continual removal of H3K9 mehylation by jmjd2 demethylases is vital for ESC selfrenewal and early development.

Pedersen and colleagues present mouse knockout data for Jmjd2a and Jmjd2a that strongly support a redundant role within ESCs. Their evidence is based on phenotypic and genome-wide sequencing experiments. Overall, the data and manuscript are well developed. There are a few points that should be addressed before being published.
We would like to thank the referee for the positive comments on our manuscript.
Concerns: 1-This manuscript builds the case they are redundant and bind the same positions. Do they bind at the same time? Chip-reChip would be required at the targets elucidated. Do these proteins interact in vivo (not with forced overexpression)?
The data presented in Fig 4G indicate that while Jmjd2a and Jmjd2c occupy the same binding sites, they are not dependent on each other for their interaction with chromatin.
There is evidence in literature that Jmjd2a and Jmjd2c directly interact when overexpressed (PMID 17207460, PMID 21694756) at least in some cell types. As suggested by the referee, we have performed reChIP experiments to determine whether Jmjd2a and Jmjd2c simultaneously bind to H3K4me3 positive TSSs. These data are included in Appendix Fig S4D-E and suggest that Jmjd2a/c do not occupy the same binding sites at the same time. The reChIP data therefore also do not argue for a direct interaction between Jmjd2a and Jmjd2c.
2-Are the authors' sure that Jmjd2a enzyme activity are required. They show Jmjd2c but not
Jmjd2a. In Drosophila, the activity was not required.
Here we would like to point out that there are relevant inter-species differences in the function of the Jmjd2 proteins. Mammals express 4 Jmjd2 proteins (A-D) that target both H3K9me2/me3 and H3K36me2/me3. In Drosophila, the Jmjd2 family contains 2 proteins namely, dJMJD2A and dJMJD2B. Notably, dJMJD2A targets H3K36me3, but not H3K9me3 (PMID 23195220).
We have attempted to ectopically express wt Jmjd2a and a catalytic mutant version in mouse ESCs in order to perform rescue experiments similar to the ones performed with Jmjd2c (Fig 7) . We've tested several different vector systems, but unfortunately, we have not been able to obtain relevant expression levels of Jmjd2a in the OHT treated cells. This could be due to the post-translational cell cycle dependent regulation of Jmjd2a protein levels (PMID 21145482 and PMID 21757720). Nevertheless, we would argue that our data strongly suggest that the catalytic activity of Jmjd2a is indeed required: We find that Jmjd2a and Jmjd2c bind independently to their targets and do not bind at the same time. The rescue data with Jmjd2c show that the catalytic activity, and hence the changes in the chromatin structure surrounding H3K4me3 positive TSSs, is required for the phenotype. The single KO ESCs do not show any of the molecular and biological changes we observe in the 2ac KO ESCs. These findings make a strong case for the involvement of the catalytic activity of Jmjd2a. I.e. in case of Jmjd2c KO cells, the most likely compensation mechanism to maintain the normal chromatin profile is the catalytic activity of Jmjd2a. Figure 5b . The H3K36me3 data should be included in Figure  5 .
3-The heat maps are often hard to interpret because the experimental verssu controls are hard to separate. Examples in supplement and
We have added vertical lines to make the heat maps easier to interpret (Fig 4C, Fig 5B and Fig  EV3B) . Due to space limitations and visibility of the data, we have not moved the H3K36me3 data to the main Fig 5, but instead present these in the Expanded View section (Fig EV3B) .
4-Figure 6d does not match the text description. It seems up-regulated and no change both have clear increase in K36me3. So how does transcription explain the observation? Also up-regualted in the not-bound show no change in K36me3.
We thank the reviewer for pointing out this mistake. The plots with 'no change' and 'upregulated' were mislabeled and this has been corrected in the new Fig 6C-D and Fig EV5 .
5-The graph throughout need stats. For Figure 2i,j, there needs to be expanded graph so can see if changes occur.
We have included statistics throughout the paper, where appropriate. Several of our figures show representative experiments, where the error bars represent technical replicates. For those graphs, statistical tests are not appropriate. We have adjusted the relevant materials and methods sections as well as figure legends, so that this is clearly indicated. We have placed graphs in which the lower region of the Y-axes of Figure 2I ,J are extended in Appendix FigS2C-D.
6-The manuscript starts with endoderm association and then does not relate the molecular results to this other than develop GO. This aspect needs better development.
It is important to note that in ESCs the spontaneous differentiation towards primitive Endoderm was occurring in the presence of serum, while the mechanistic studies were performed on cells grown in 2i medium. This was done to ensure homogeneity of the analysed cell populations and to prevent confounding effects of differentiated cells in the culture. This setup allowed us to point to the initial responsible mechanism, rather than more downstream phenotypic changes. While the array analyses therefore did not recapitulate e.g. the altered expression of endodermal markers observed in serum culture, our mechanistic studies nevertheless allowed us to identify several Jmjd2a/c targets, which could contribute to the observed phenotypes.
We have clarified the main text on these points (page 13-15) and added more information about culture conditions to the appropriate figure legends. Figure 2 show a modest effect. This should be stated and not underplayed. It could be more pronounced in vivo. Annexin or some other method should be used to evaluate the "apoptosis".
7-The cell cycle analyses in
It is correctly noticed that the cell cycle analyses in Figure 2 reveal minor alterations. However, we know from independent analyses that the observed trends are not robust. In contrast, we repeatedly observe increased levels of cell death and impaired mitosis in 2ac and 2abc ko ESCs, and we therefore focus on these observations in the text. We've altered figure panel 2E so that the proportion of dead cells (subG1, events with a <2N DNA content) is now clearly indicated. As a measure for apoptotic cell death, we performed Western blot analysis of cleaved Caspase 3, which is presented in Appendix Fig S2A. Figure S5a needs quantification. The data does not suggest or prove the enzymes are responsible for demethylation to H3K9me1. This suggestion should be softened.
8-The data in
In addition, the text describing the data has been modified and now reads 'The Jmjd2 enzymes catalyse the demethylation of lysine 9 and lysine 36 on histone H3 and increased levels of H3K9me3 and H3K36me3 could be detected for both 2ac and 2abc KO ESCs by WB'.
Minor comment:
The authors' should conform to the nomenclature for the lysine demethylases or mention the names so that readers can find this study.
We have now included the names from the KDM nomenclature in the abstract, the introduction and the results section.
2nd Editorial Decision 06 May 2016
Thank you for submitting a revised version of your manuscript, it has now been seen by two of the original referees whose comments are shown below. As you will see they both find that all criticisms have been sufficiently addressed and I am therefore happy to inform you that your manuscript has been accepted for publication in The EMBO Journal.
Before we can go on to transfer your files for production I have to ask you to clarify a few remaining editorial points:
-> I noticed that the figure legends in several instances (figs 1, 3, 6 and 7) state 'Data are representative of results obtained in at least 2 independent experiments, and graphs show mean {plus minus} SD' and I would ask you to also include the exact number of replicas used for calculating statistics in the legend (I assume you mean that data represents {greater than or equal to}3 replicas for each of the 2 independent experiments?). A word file with updated information can be sent to me directly by email and we can then upload it in house. In cases where only two biological replicas are available, we would ask you to display individual data points in the figures instead.
-> As you know, we generally encourage the publication of source data, particularly for electrophoretic gels and blots, with the aim of making primary data more accessible and transparent to the reader. We would need 1 file per figure (which can be a composite of source data from several panels) in jpg, gif or PDF format, labelled as "Source data files". The gels should be labelled with the appropriate figure/panel number, and should have molecular weight markers; further annotation would clearly be useful but is not essential. These files will be published online with the article as a supplementary "Source Data" and can be sent to us directly by email.
-
The authors satisfactorily addressed my major concerns.
Referee #2:
The revision has addressed my main concern and provides the required reproducibility measures for the genotype specific changes in histone modifications. It is thus suitable for publication. 
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation. a statement of how many times the experiment shown was independently replicated in the laboratory.
Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
Please ensure that the answers to the following questions are reported in the manuscript itself. We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
In the pink boxes below, provide the page number(s) of the manuscript draft or figure legend(s) where the information can be located. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable).
B--Statistics and general methods
the assay(s) and method(s) used to carry out the reported observations and measurements an explicit mention of the biological and chemical entity(ies) that are being measured. an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner. the exact sample size (n) for each experimental group/condition, given as a number, not a range; a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified
YOU MUST COMPLETE ALL CELLS WITH A PINK BACKGROUND 
No statistical method was used to predetermine sample size.
No statistical method was used to predetermine sample size. Animals/samples were allocated to groups based on genotype. No animals or samples were excluded from any analyses. Animals/samples were allocated to groups based on genotype.
No randomization was used.
NA Animals/samples were allocated to groups based on genotpye.
No blinding was done. 
C--Reagents
All statistical tests were justified as appropriate.
The data meet the assumptions of the used tests.
The modified t--test from the 'limma' R--package has a builtin robust variance estimation algorithm (microarray RNA expression analysis). For the average density plots we estimated and depicted the 95% confidence intervals of the mean. For the microarray RNA expression analysis we used the modified t--test in the 'limma' R--package with default settings, which does assume equal variances of groups.
